Jump to navigation

Vol 62 No 11

Published 27th May 2021

Parting on patents

United States President Joe Biden's backing for an unlikely patent-waiver for Covid-19 vaccines is deft political manoeuvring. It announced the USA's return as lead player international development issues and fired a shot across the bows of the international pharmaceutical companies whose control over intellectual property was seen as beyond the reach of price controls by politicians. Biden's announcement came just before publication of the report of the Independent Panel for Pandemic Preparedness and Response chaired by Liberia's former president Ellen Johnson Sirleaf, and Helen Clark, former Prime Minister of New Zealand. The report called for a much more equitable drug and vaccine availability during a pandemic.

End of preview - This article contains approximately 299 words.

End of preview

Subscribers: Log in now to read the complete article.

Account Holders: Log in now and use your Account Credit to buy this article. No Credit? Top up your Account now.

If you are logged in, but still cannot access the full text of this article, email customer services or telephone us on +44(0)1638 743633.